KATO Mitsuyasu

Researcher's full information

Articles
  • Alternatively-Spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3.
    Yagi K; Goto D; Hamamoto T; Takenoshita S; Kato M; Miyazo...
    J. Biol. Chem./274/pp.703-709, 1999-01
  • Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.
    Fujii M; Takeda K; Imamura T; Aoki H; Sampath TK; Enomoto...
    Mol. Biol. Cell/10/pp.3801-3813, 1999-01
  • Expression of transforming growth factor-beta superfamily and their receptors in the corneal stromal wound healing process after excimer laser keratectomy.
    Kaji Y; Mita T; Obata H; Tsuru T; Soya K; Shirasawa E; Sa...
    Br J Ophthalmol./82(4)/pp.462-463, 1998-04
  • Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases.
    Nakamura K; Yasaka N; Asahina A; Kato M; Miyazono K; Furu...
    J. Dermatol. Sci./18/pp.170-180, 1998-01
  • Heterogeneous smooth muscle cell population derived from small and larger arteries.
    Nakamura A; Isoyama S; Watanabe T; Kato M; Sawai T
    Microvasc. Res./55/pp.14-28, 1998-01
  • Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
    Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato ...
    Bone/22/pp.14-28, 1998-01
  • Distinct and overlapping patterns of localization of BMP family members in and surrounding cells that co-express BMP type II receptor and type I receptors during fracture healing in rats.
    Onishi T; Ishidou Y; Nagamine T; Yonemori K; Yone K; Imam...
    Bone/22/pp.605-612, 1998-01
  • A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-β signals.
    Goto D; Yagi K; Inoue H; Iwamoto I; Kawabata M; Miyazono ...
    FEBS letters/430/pp.201-204, 1998-01
  • Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma with clinically apparent cervical lymphadenopathy.
    Sugitani I; Yanagisawa A; Shimizu A; Kato M; Fujimoto Y
    World J. Surg./22/pp.731-737, 1998-01
  • Immunohistochemical detection of activin A, follistatin, and activin receptors during fracture healing in the Rat.
    Nagamine T; Imamura T; Ishidou Y; Kato M; Eto Y; Sakai R...
    J. Orthop. Res./16/pp.314-321, 1998-01
  • Effects of transforming growth factor β on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy.
    Mita T; Yamashita H; Kaji Y; Obata H; Yamada H; Kato M; H...
    Graefe's Arch. Clin. Exp. Ophthalmol./236/pp.834-843, 1998-01
  • Identification of receptors and Smad proteins involved in activin-induced differentiation of human epidermal keratinocytes.
    Shimizu A; Kato M; Nakao A; ten Dijke P; Heldin C-H; Imam...
    Genes Cells/3/pp.125-134, 1998-01
  • Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in Ossification of the ligamentum flavum.
    Hayashi K; Ishidou Y; Yonemori K; Nagamine T; Origuchi N...
    Bone/21/pp.23-30, 1997-01
  • Growth/differentiation factor-5 induces angiogenesis in vivo.
    Yamashita H; Shimizu A; Kato M; Nishitoh H; Ichijo H; Han...
    Exp. Cell Res./235/pp.218-226, 1997-01
  • Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor β1 and overexpression of bcl-2.
    Saeki K; Yuo A; Kato M; Miyazono K; Yazaki Y; Takaku F
    J. Biol. Chem./272/pp.20003-20010, 1997-01
  • Dysregulated expression of transforming growth factor β (TGF-β) and its type I and type II receptors in basal cell carcinoma.
    Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi...
    Int. J. Cancer/71/pp.505-509, 1997-01
  • Extracellular fibrillar structure of latent TGFβ binding protein-1: role in TGFβ-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart.
    Nakajima Y; Miyazono K; Kato M; Takase M; Yamagishi T; Na...
    J. Cell Biol./136/pp.193-204, 1997-01
  • Expression of CD34 in glomus tumors.
    Hatori M; Aiba S; Kato M; Kamiya N; Kokubun S
    Tohoku J. Exp. Med./182/pp.241-247, 1997-01
  • Orthotopic ossification of the spinal ligaments of Zucker fatty rats: a possible animal model for ossification of the human posterior longitudinal ligament.
    Okano T; Ishidou Y; Kato M; Imamura T; Yonemori K; Origuc...
    J. Orthop. Res./15/pp.820-829, 1997-01
  • Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.
    Yonemori K; Imamura T; Ishidou Y; Okano T; Matsunaga S; Y...
    Am. J. Pathol./150/pp.1335-1347, 1997-01
  • Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with α3β1 integrin.
    Okochi H; Kato M; Nashiro K; Yoshie O; Miyazono K; Furue M
    Brit. J. Dermatol./137/pp.856-863, 1997-01
  • Differential localization of TGF-β-precursor isotypes in psoriatic human skin.
    Wataya-Kaneda M; Hashimoto K; Kato M; Miyazono K; Yoshika...
    J. Dermatol. Sci./11/pp.183-188, 1996-01
  • Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissue.
    Kim IY; Ahn H-J; Zelner DJ; Shaw JW; Lang S; Kato M; Oefe...
    Clin. Cancer Res./2/pp.1255-1261, 1996-01
  • Expression of TGF-β type I and type II receptors in rat eyes.
    Obata H; Kaburaki T; Kato M; Yamashita H
    Curr. Eye Res./15/pp.335-340, 1996-01
  • Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue.
    Kai T; Taketazu F; Kawakami M; Shimanuki K; Yamada S; Miy...
    Jpn. J. Cancer Res./87/pp.296-304, 1996-01
  • more...